Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06412718
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-04-30
Brief Title:
Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies
Sponsor:
IRCCS Ospedale San Raffaele
Organization:
IRCCS Ospedale San Raffaele
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Corneal Neovascularization |
| Rare Diseases |
| Aniridia |
| Neurotrophic Keratopathy |
| Limbal Stem Cell Deficiency |
| Ocular Graft-versus-host Disease |
| Ocular Cicatricial Pemphigoid |
| EEC Syndrome |
Keywords:
| Name | View |
|---|---|
| Cytokine | View |
| Rare Eye Diseases | View |
| Aniridia | View |
| Neurotrophic Keratopathy | View |
| Limbal Stem Cell Deficiency | View |
| Ocular Graft-versus-host Disease | View |
| Ocular Cicatricial Pemphigoid | View |
| Corneal Neovascularization | View |
| Molecular targets | View |
| Cellular targets | View |
| Genomic targets | View |
| NK1R | View |
| PBMC | View |
| Substance P | View |
| VEGF | View |
| Blood | View |
| Tear | View |
| Impression cytology | View |